Alert: Ebola could reach 20,000 people by November, according to WHO

The current Ebola epidemic is the worst on record. The virus, so far, is located in West African countries, but there is a threat that the disease will spread throughout the African continent, and may migrate to other nearby continents, such as Europe and Asia.
To date, the World Health Organization (WHO) has recorded 3091 deaths out of a total of 6574 possible cases. The country with the most reports is Liberia, with 1830 deaths. The number of deaths in that country is almost three times higher than the cases in Guinea and Sierra Leone. Nigeria and Senegal, which also had cases of the disease, reported no more Ebola deaths.
But the data is even more worrying. According to Christopher Dye, WHO strategy manager, the number of cases could reach 20,000 in November of that year. In a study released by the WHO and carried out in partnership with the Imperial College in London, England, this number could jump to hundreds of thousands if the outbreak is not controlled.

Christopher Rye calls for more efforts to be made in order to contain the disease. The United Nations is trying to raise funds to fight the outbreak, which is already classified by the Security Council as a threat to world peace.

Vaccine

The WHO recently announced that experimental vaccines to combat the Ebola virus will be available in 2015. These vaccines are being produced by pharmaceutical companies GSK and NewLink Genetics.

The production of this vaccine has raised ethical conflicts. It usually takes years for a vaccine to be approved for use in humans, and tests are needed to prove its effectiveness and safety. However, in the case of Ebola, as it is a very serious disease that kills at a high rate, the approval process will have to be accelerated.

It is now being discussed whether these experimental vaccines should be offered first to health professionals who are caring for those infected, as well as to caregivers who are in the affected areas. Once safety is proven in these people, use would be extended to patients in risk regions.

The vaccines tested so far have good results in monkeys, according to a recent study published in the prestigious scientific journal, Nature.

Read also: Ebola epidemic is out of control – Scientists discover protein that blocks the release of HIV and Ebola viruses

Jeanne Kenney
 | Website

I’m a stylist trainer, a content creator, and an entrepreneur passion. Virgo sign and Pisces ascendant, I move easily between my dreams, the crazy world I want, and my feet on the ground to carry out my projects.

Leave a Reply

Your email address will not be published. Required fields are marked *